This inventor holds 2 USPTO granted patents. Top assignee: Mathilda and Terence Kennedy Institute of Rheumatology. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1999
Title: Inventor Martin John Turner: Pioneering Advances in Rheumatology
Introduction
Martin John Turner, based in Ann Arbor, Michigan, is a notable inventor recognized for his significant contributions to the field of rheumatology. With two patents to his name, Turner has made strides in developing innovative solutions to tackle diseases mediated by tumor necrosis factor alpha (TNF-alpha).
Latest Patents
One of Turner's latest patents is focused on a nucleic acid encoding modified human TNF-alpha. This patent outlines a DNA molecule that encodes a polypeptide capable of binding human TNF-alpha, incorporating the first three cysteine-rich subdomains of a receptor but excluding the fourth. This innovative approach provides a potential treatment avenue for diseases influenced by TNF-alpha activity, such as rheumatoid arthritis.
Alongside this, his work on TNF-alpha receptor-derived binding protein further underscores his commitment to advancing medical therapies in this critical area.
Career Highlights
Martin John Turner has been recognized for his scientific contributions while working at the Mathilda and Terence Kennedy Institute of Rheumatology. His research efforts focus on understanding and addressing the mechanisms behind inflammatory diseases, leading to the development of novel therapeutic strategies.
Collaborations
Throughout his career, Turner has collaborated with esteemed researchers such as Marc Feldmann and Patrick William Gray. These partnerships have been instrumental in fostering innovative ideas and expanding the reach of his research in the rheumatology community.
Conclusion
In conclusion, Martin John Turner exemplifies the spirit of innovation in his pursuit of advancing treatments for diseases mediated by TNF-alpha. His patents not only showcase his ingenuity but also highlight his dedication to improving patient outcomes in the field of rheumatology. Turner's work continues to inspire both current and future inventors aiming to make a difference through scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile